Cromwell Holdings’s Genpact G Stock Holding History

Cromwell Holdings’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$468	Sell	17 -9	-35%	-$296	﹤0.01%	1056
2026 Q1	$969	Buy	26 +8	+44%	+$330	﹤0.01%	869
2025 Q4	$842	Hold	18	–	–	﹤0.01%	863
2025 Q3	$755	Hold	18	–	–	﹤0.01%	900
2025 Q2	$792	Buy	+18	New	+$815	﹤0.01%	859

Other funds holding G

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NIEF

Nalanda India Equity Fund Mauritius $377M AUM 37.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cromwell Holdings's G Position: Q2 2026 in Review

Cromwell Holdings reduced its Genpact (G) stake by 35% in Q2 2026, selling an estimated $296 and leaving 17 shares worth $468. The position accounts for ﹤0.01% of the portfolio, ranked #1056.

Cromwell Holdings first reported a position in G in Q2 2025 and has held it in 5 quarters since. The position peaked at $969 in Q1 2026. 478 funds tracked by Wall St. Rank hold G as of Q2 2026.

Cromwell Holdings held 17 shares of Genpact worth $468 as of Q2 2026.
Cromwell Holdings sold 9 Genpact shares in Q2 2026, an estimated $296.
Genpact made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #1056 holding.
Cromwell Holdings first reported a position in Genpact in Q2 2025 and has held it in 5 quarters since.
Cromwell Holdings's Genpact position peaked at $969 in Q1 2026.
478 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.